Status:
COMPLETED
Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT
Lead Sponsor:
Hartford Hospital
Collaborating Sponsors:
Bracco Diagnostics, Inc
Conditions:
Coronary Artery Disease
Myocardial Ischemia
Eligibility:
All Genders
50+ years
Brief Summary
Many stress tests being done today have two parts, the stress test and the pictures of your heart. The investigators are comparing a newer technique to obtain the pictures (PET imaging) to the standar...
Detailed Description
A SPECT rest image will be obtained using a technetium based isotope. On a separate day, a Rubidium rest PET image will be obtained prior to a Dipyridamole stress test. Subjects will receive both Rubi...
Eligibility Criteria
Inclusion
- referred for clinical cardiac catheterization
Exclusion
- previous CABG
- previous MI
- Asthma or obstructive airway disease
- Intolerance to Dipyridamole
- Moderate to severe valvular disease
- Cardiomyopathy - (ejection fraction less than 45%)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01179230
Start Date
January 1 2005
End Date
December 1 2012
Last Update
March 23 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
The Heart Center, PC
Huntsville, Alabama, United States, 35801
2
Hartford Hospital
Hartford, Connecticut, United States, 06102-5037
3
Cardiovascular Imaging Technologies, LLC
Kansas City, Missouri, United States, 64111
4
Sanford Health Clinical Research
Fargo, North Dakota, United States, 58122-0011